U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Giractide is a polypeptide hormone corresponding to the first eighteen amino acid residues of corticotropin in which the 1-serine is replaced by glycine. Giractide acts through the stimulation of cell surface the adrenocorticotropic hormone (ACTH) receptors, which are primarily located on the adrenocortical cells. Giractide stimulates the cortex of the adrenal gland and boosts the synthesis of corticosteroids, mainly glucocorticoids but also sex steroids (androgens). Giractide has been studied in animal models to stimulate glucocorticoid production.

Approval Year

Substance Class Protein
Created
by admin
on Mon Mar 31 20:59:59 GMT 2025
Edited
by admin
on Mon Mar 31 20:59:59 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
EQ3RIK9PVT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GIRACTIDE
INN   MI  
INN  
Official Name English
GIRACTIDE [MI]
Preferred Name English
giractide [INN]
Common Name English
Code System Code Type Description
INN
3199
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY
ChEMBL
CHEMBL2370090
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY
MERCK INDEX
m5733
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY Merck Index
SMS_ID
100000080398
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY
EVMPD
SUB07906MIG
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY
CAS
24870-04-0
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY
FDA UNII
EQ3RIK9PVT
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY
NCI_THESAURUS
C170027
Created by admin on Mon Mar 31 20:59:59 GMT 2025 , Edited by admin on Mon Mar 31 20:59:59 GMT 2025
PRIMARY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
C-TERMINAL MODIFICATION [1_18] ARGININE ARGININAMIDE, L- 29626ZE0WY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL